MONYETTA EVERETT
Allopathic & Osteopathic Physicians|Family Medicine RIDGELAND, MS NPI 1861969552
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MS ABBVIE INC. All categories
General Payments — all program years on this page
$203.40
- Category: General Payments
- Program years: PY2021–2022
- Record count: 13
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $133.73 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $133.73 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $55.17 | 3 |
| Nabriva Therapeutics, plc | $32.60 | 2 |
| Lilly USA, LLC | $18.94 | 1 |
| Genentech USA, Inc. | $13.96 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.06 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 887741777 | Boehringer Ingelheim Pharmaceuticals, Inc. | $13.06 | 08/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 891843799 | ABBVIE INC. | $12.83 | 01/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 891843801 | ABBVIE INC. | $18.41 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 891843803 | ABBVIE INC. | $23.93 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 918649743 | Lilly USA, LLC | $18.94 | 07/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 950673383 | Genentech USA, Inc. | $13.96 | 02/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 961087219 | Nabriva Therapeutics, plc | $16.13 | 06/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 961087221 | Nabriva Therapeutics, plc | $16.47 | 04/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.